Sands Capital Life Sciences Pulse Fund II, L.P. 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-22 4:32 pm Sale | 2023-06-20 | 13D | DICE THERAPEUTICS INC DICE | Sands Capital Life Sciences Pulse Fund II, L.P. | 1,886,470 4.000% | -1,262,500 (-40.09%) | Filing |
| 2021-09-24 6:12 pm Purchase | 2021-09-17 | 13D | DICE THERAPEUTICS INC DICE | Sands Capital Life Sciences Pulse Fund II, L.P. | 3,148,970 8.700% | 3,148,970 (New Position) | Filing |